The RPS27A gene helps cells make proteins by supporting ribosomes, the cell structures that build them, and by supplying ubiquitin, a small tag used in protein recycling. If it does not work properly, cells may have trouble growing, dividing, and handling stress. This gene plays an important role in tissues that renew often, such as blood and skin. Changes affecting the RPS27A gene are mainly studied for their effects on basic cell function and in cancer research.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to explore this topic in more detail, you can learn more in the LearnHub.
Overview
RPS27AGene function
What if the gene works
The RPS27A gene helps cells make proteins by supplying part of a ribosome, the cell’s protein making machinery. It also provides a small protein label that helps cells recycle worn out proteins.
Risk
What if the gene does not work
Variants in the RPS27A gene can range from mild to more severe and may weaken ribosome assembly, so cells make proteins less efficiently. Some variants may also reduce a protein tag that helps cells recycle proteins.
Treatment
What does that mean for your treatment
No RPS27A-specific treatment or management approach is currently established in clinical guidelines; care is based on the person’s diagnosed condition and symptoms rather than a pathogenic variant in the RPS27A gene itself. The RPS27A gene is being studied in cancer research as a possible biomarker and drug target, but this has not yet changed routine treatment decisions.
Gene function
What if the gene works
Every day, your cells need to make new proteins and clear out old ones. The RPS27A gene supports both jobs by producing a starter protein that is split into two useful parts. This helps explain what the RPS27A gene does in your cells: one part joins the protein-making machinery, and the other becomes ubiquitin, a small tag used for routine protein control.
One part from the RPS27A gene becomes S27a, a piece of the small ribosome, the cell's protein-making machine. It helps the ribosome read messenger RNA (the cell's protein recipe) so proteins are assembled in the right order.
Another part becomes ubiquitin, a small tag that cells attach to proteins to guide their normal handling. This tagging can help mark proteins for recycling, move them to the right place, or fine tune how long they stay active.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the RPS27A gene can alter how much usable protein is made, how stable it is, or how well it is cut into its working parts. In plain language, this is how RPS27A gene variants affect cells: some changes partly reduce ribosome assembly (the cell’s protein making machinery), while more disruptive variants can cause a larger loss of function. Milder variants may leave some activity intact, while severe variants can interfere more strongly with protein production and related cell processes.
How variants are linked to conditions
The RPS27A gene does not yet have a broadly confirmed link to a specific health condition, though this can change as research develops. Current evidence on RPS27A gene variants linked to conditions has not established a main RPS27A-related diagnosis used in routine medical care.
A variant is not necessarily a diagnosis
Genetic variants are common throughout the population and are a usual part of human biology. Most do not directly affect health and simply contribute to the range of natural human diversity. In many genes, a variant associated with a condition suggests a possible link rather than proving a diagnosis, especially when several genes and environmental factors are part of the picture. Still, there are situations in which one well-characterized variant in a specific gene can by itself confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RPS27A gene. If testing has found a change in RPS27A, a doctor or genetic counselor can help explain what it may mean in the context of your personal and family history.
Inheritance of RPS27A variants
There is not yet a broadly confirmed, disease-associated Mendelian inheritance pattern for the RPS27A gene, so the answer to how RPS27A gene variants are inherited is still being clarified as research develops. The RPS27A gene is located on chromosome 2, which is an autosome. That means a person inherits one copy of the RPS27A gene from each parent.
What does my RPS27A result mean for my family?
A disease-causing change in the RPS27A gene can be passed down in families in a dominant pattern, so close relatives such as parents, siblings, and children may also carry the same result. This can matter even when symptoms are mild or different from one family member to another. Some cases happen for the first time in one person, so a parent does not always have the same gene change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the RPS27A gene, doctors use genetic testing for RPS27A variants on a blood or saliva sample. A lab reads the gene's DNA sequence and compares it with the usual reference sequence. The report states whether a variant was found and how it is currently classified.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order genetic testing specifically for the RPS27A gene. Testing decisions are usually based on your symptoms, personal health history, and family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can offer useful insight, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, so the same treatment may work well for one person but less well for another. Part of the reason is that inherited differences can change how the body absorbs, breaks down, or responds to a drug. These differences are common and can influence how much benefit a medicine provides or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. You can explore this topic further in the LearnHub.
Drugs influenced by the RPS27A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how someone will respond to medicines, so general medication questions or new symptoms are best discussed with your doctor.
History
RPS27A entered genetics through work on ribosomal proteins and ubiquitin in the late 1980s, when researchers realized that some human genes produce a single starting protein that is later split into separate parts. Initially understood only through visible traits, later recognized as tied to a specific gene, this finding helped connect basic cell biology with human gene mapping. From these first observations, research expanded steadily. By the 1990s, the RPS27A gene had been cloned and placed on chromosome 2, giving scientists a clearer picture of how this small but widely active gene fit into the human genome. Its history is mainly a laboratory story rather than a public one, shaped by advances in sequencing, gene mapping, and studies of how cells build proteins.